298 related articles for article (PubMed ID: 18448355)
41. Hyaluronidases in tissue invasion.
Csóka TB; Frost GI; Stern R
Invasion Metastasis; 1997; 17(6):297-311. PubMed ID: 9949289
[TBL] [Abstract][Full Text] [Related]
42. RBM5/LUCA-15--tumour suppression by control of apoptosis and the cell cycle?
Mourtada-Maarabouni M; Williams GT
ScientificWorldJournal; 2002 Jul; 2():1885-90. PubMed ID: 12920317
[TBL] [Abstract][Full Text] [Related]
43. Hyaluronidases: A Therapeutic Enzyme.
Khan N; Niazi ZR; Rehman FU; Akhtar A; Khan MM; Khan S; Baloch N; Khan S
Protein Pept Lett; 2018; 25(7):663-676. PubMed ID: 29956608
[TBL] [Abstract][Full Text] [Related]
44. Oncogenes and tumor suppressor genes.
Carbone DP
Hosp Pract (Off Ed); 1993 Jun; 28(6):145-8, 153-6, 161. PubMed ID: 8509476
[TBL] [Abstract][Full Text] [Related]
45. Sperm penetration through oocyte investments in mammals.
Talbot P
Am J Anat; 1985 Nov; 174(3):331-46. PubMed ID: 4072945
[TBL] [Abstract][Full Text] [Related]
46. Embryonic genes in cancer.
Calvo R; Drabkin HA
Ann Oncol; 2000; 11 Suppl 3():207-18. PubMed ID: 11079143
[TBL] [Abstract][Full Text] [Related]
47. [Introduction to the process of oncogenesis: cancers are somatic genetic diseases].
Janin N
Rev Med Interne; 1994; 15(12):821-9. PubMed ID: 7863117
[TBL] [Abstract][Full Text] [Related]
48. How cancers escape their oncogene habit.
Giuriato S; Felsher DW
Cell Cycle; 2003; 2(4):329-32. PubMed ID: 12851484
[TBL] [Abstract][Full Text] [Related]
49. Loss of cancer suppressors, a driving force in carcinogenesis.
Bouck NP; Benton BK
Chem Res Toxicol; 1989; 2(1):1-11. PubMed ID: 2519224
[No Abstract] [Full Text] [Related]
50. The regulation of tumor suppressor genes by oncogenes.
Dent P; Qiao L; Gilfor D; Birrer M; Grant S; Fisher PB
Methods Mol Biol; 2003; 222():269-92. PubMed ID: 12710693
[No Abstract] [Full Text] [Related]
51. Progress in molecular biology of breast cancer.
Mooi WJ; Peterse JL
Eur J Cancer; 1992; 28(2-3):623-5. PubMed ID: 1350455
[No Abstract] [Full Text] [Related]
52. Oncogenes and growth factors--an updating.
Ernberg IT
Eur J Surg Suppl; 1991 May; (561):15-20. PubMed ID: 1720043
[No Abstract] [Full Text] [Related]
53. KLF4, p21 and context-dependent opposing forces in cancer.
Rowland BD; Peeper DS
Nat Rev Cancer; 2006 Jan; 6(1):11-23. PubMed ID: 16372018
[TBL] [Abstract][Full Text] [Related]
54. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
[TBL] [Abstract][Full Text] [Related]
55. ATF2: a transcription factor that elicits oncogenic or tumor suppressor activities.
Bhoumik A; Ronai Z
Cell Cycle; 2008 Aug; 7(15):2341-5. PubMed ID: 18677098
[TBL] [Abstract][Full Text] [Related]
56. Oncogenes and tumor-suppressor genes in mesothelioma--a synopsis.
Lechner JF; Tesfaigzi J; Gerwin BI
Environ Health Perspect; 1997 Sep; 105 Suppl 5(Suppl 5):1061-7. PubMed ID: 9400701
[TBL] [Abstract][Full Text] [Related]
57. A working model for the time sequence of genetic changes in breast tumorigenesis.
Singletary SE
J Am Coll Surg; 2002 Feb; 194(2):202-16. PubMed ID: 11848636
[No Abstract] [Full Text] [Related]
58. Oncogenes and antioncogenes in lung tumorigenesis.
Giaccone G
Chest; 1996 May; 109(5 Suppl):130S-134S. PubMed ID: 8635391
[TBL] [Abstract][Full Text] [Related]
59. [Oncogenes, tumor suppression genes and medical genetics of cancer].
Bootsma AH; Cornelisse CJ; de Klein A
Ned Tijdschr Geneeskd; 1992 May; 136(21):1009-13. PubMed ID: 1318508
[No Abstract] [Full Text] [Related]
60. The role of Notch in tumorigenesis: oncogene or tumour suppressor?
Radtke F; Raj K
Nat Rev Cancer; 2003 Oct; 3(10):756-67. PubMed ID: 14570040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
